BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28731051)

  • 1. Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.
    Varey AHR; Goumas C; Hong AM; Mann GJ; Fogarty GB; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Lee KJ; Quinn MJ; Thompson JF; Scolyer RA
    Mod Pathol; 2017 Nov; 30(11):1538-1550. PubMed ID: 28731051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
    Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
    Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival.
    Laeijendecker AE; El Sharouni MA; Sigurdsson V; van Diest PJ
    Cancer Med; 2020 Jan; 9(2):671-677. PubMed ID: 31804771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
    Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
    J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
    May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
    Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases.
    Chen JY; Hruby G; Scolyer RA; Murali R; Hong A; Fitzgerald P; Pham TT; Quinn MJ; Thompson JF
    Cancer; 2008 Nov; 113(10):2770-8. PubMed ID: 18823042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
    Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
    Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy.
    Ranieri JM; Wagner JD; Azuaje R; Davidson D; Wenck S; Fyffe J; Coleman JJ
    Ann Surg Oncol; 2002 Dec; 9(10):975-81. PubMed ID: 12464589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
    Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
    Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
    Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
    Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.
    Jones EL; Jones TS; Pearlman NW; Gao D; Stovall R; Gajdos C; Kounalakis N; Gonzalez R; Lewis KD; Robinson WA; McCarter MD
    JAMA Surg; 2013 May; 148(5):456-61. PubMed ID: 23325294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Ipenburg NA; Nieweg OE; Ahmed T; van Doorn R; Scolyer RA; Long GV; Thompson JF; Lo S
    Br J Surg; 2019 Sep; 106(10):1319-1326. PubMed ID: 31310333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas.
    Pasquali S; Haydu LE; Scolyer RA; Winstanley JB; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
    Ann Surg; 2013 Jul; 258(1):152-7. PubMed ID: 23426339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
    Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
    Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.